Arzeda

Arzeda Corp is a Seattle, Washington protein design company — "The Protein Design Company" — founded in 2008 by David Baker (2024 Nobel Prize in Chemistry), Alexandre Zanghellini and colleagues out of the University of Washington Institute for Protein Design. Its Intelligent Protein Design Technology combines physics-based computational protein design, generative AI and an agentic design-build-test-learn loop over fifteen years of proprietary in-house experimental data to create designer enzymes and proteins that do not exist in nature, then scale them to commercial production. Commercial programs span food and beverage (ViaLeaf Reb M / ProSweet Reb M stevia sweeteners with MANE), home and personal care enzymes (Unilever), advanced materials (W. L. Gore & Associates) and pharmaceutical biologics (Takeda), alongside DARPA and NSF funded work on AI-driven protein design and cell-free biomanufacturing. Arzeda co-founded the OpenFold consortium for open-source protein structure prediction. It sells designed molecules and joint development programs, not software, and publishes no public developer program, API or machine-readable interface.

Arzeda is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Synthetic Biology, Protein Design, and Enzymes.

Arzeda’s developer surface includes engineering blog, product news, and 12 more developer resources.

🌐 Visit website 📡 Source on GitHub

6.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologySynthetic BiologyProtein DesignEnzymesArtificial IntelligenceLife SciencesSpecialty ChemicalsFood IngredientsMaterials SciencePharmaceuticalsSeattle

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 6.3/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Commercial Clarity 0.0 / 17

Operational Transparency 0.6 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/arzeda: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Company 7

The organization behind the API

Website

About

Blog

News

Careers

LinkedIn

Twitter

Twitter

Scroll for all 7

Other 4

Properties that don't map to a standard resource type

Technology

Publications

Team

Sitemap

Source (apis.yml)

aid: arzeda
name: Arzeda
description: Arzeda Corp is a Seattle, Washington protein design company — "The Protein Design Company" — founded in 2008
  by David Baker (2024 Nobel Prize in Chemistry), Alexandre Zanghellini and colleagues out of the University of Washington
  Institute for Protein Design. Its Intelligent Protein Design Technology combines physics-based computational protein design,
  generative AI and an agentic design-build-test-learn loop over fifteen years of proprietary in-house experimental data to
  create designer enzymes and proteins that do not exist in nature, then scale them to commercial production. Commercial programs
  span food and beverage (ViaLeaf Reb M / ProSweet Reb M stevia sweeteners with MANE), home and personal care enzymes (Unilever),
  advanced materials (W. L. Gore & Associates) and pharmaceutical biologics (Takeda), alongside DARPA and NSF funded work
  on AI-driven protein design and cell-free biomanufacturing. Arzeda co-founded the OpenFold consortium for open-source protein
  structure prediction. It sells designed molecules and joint development programs, not software, and publishes no public
  developer program, API or machine-readable interface.
image: https://www.arzeda.com/assets/logos/arzeda_clr_wht.svg
url: https://raw.githubusercontent.com/api-evangelist/arzeda/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Synthetic Biology
- Protein Design
- Enzymes
- Artificial Intelligence
- Life Sciences
- Specialty Chemicals
- Food Ingredients
- Materials Science
- Pharmaceuticals
- Seattle
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/arzeda-domain-security.yml
- type: Website
  url: https://www.arzeda.com/
- type: About
  url: https://www.arzeda.com/about
- type: Technology
  url: https://www.arzeda.com/technology
- type: Blog
  url: https://www.arzeda.com/blog
- type: News
  url: https://www.arzeda.com/news
- type: Publications
  url: https://www.arzeda.com/publications
- type: Team
  url: https://www.arzeda.com/team
- type: Careers
  url: https://www.arzeda.com/careers
- type: Contact
  url: https://www.arzeda.com/contact
- type: GitHubOrganization
  url: https://github.com/Arzeda
- type: LinkedIn
  url: https://www.linkedin.com/company/arzeda-corp
- type: Twitter
  url: https://x.com/ArzedaCo
- type: Sitemap
  url: https://www.arzeda.com/sitemap.xml
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: Arzeda sells designed enzymes, molecules and joint-development programs rather than software — its arzeda.com Webflow
    site answers every unknown path (including /openapi.json, /llms.txt and /.well-known/agent-card.json) with the identical
    97,718-byte homepage soft-404, and api./docs./developer./app./platform.arzeda.com do not resolve in DNS at all.
  evidence:
  - url: https://www.arzeda.com/openapi.json
    status: 200
  - url: https://www.arzeda.com/definitely-not-a-real-path-xyz123
    status: 200
  - url: https://www.arzeda.com/.well-known/agent-card.json
    status: 200
  - url: https://www.arzeda.com/.well-known/security.txt
    status: 200
  - url: https://www.arzeda.com/llms.txt
    status: 200
  - url: https://api.arzeda.com/
    status: 0
  - url: https://docs.arzeda.com/
    status: 0
  - url: https://www.arzeda.com/sitemap.xml
    status: 200
  checked: '2026-08-06'